Researchers Launch Breast Cancer Prevention Drug Trial
THURSDAY, March 31 (HealthDay News) -- Researchers have launched an international study to evaluate the ability of a new estrogen-suppressing drug, exemestane, to prevent breast cancer in women at increased risk for the disease.
The ExCel study will track more than 4,500 postmenopausal women in Canada, the United States and Spain for five years. Researchers say it will include women at increased risk for breast cancer due to risk factors such as age, family history, age at first menstrual period, and age at first live birth.
Full Article: http://www.healthfinder.gov/news/newsstory.asp?docid=524871